fashion -WSS

fashion

author：focus 2025-10-01 15:40:31 - browse：6

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

hotspot

WSS

Senate panel to vote on hospitals, PBMs, prisoner care

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Biogen says it will cut costs by $700 million, slash 1,000 jobs

A new crop of companies is reshaping the health data economy

Why patients can’t get everything they want on drug pricing

Will the FTC rein in IQVIA's health data empire?

knowledge

fashion

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Rise in cancer among younger people worries and puzzles doctors

Trump demands the U.S. pay no more for drugs than other countries … again

Traditional Chinese medicine benefits explored in new JAMA study

Virginia high school admissions case could be legal follow

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The battle over 'scope creep' and who gets to be called 'doctor'

Psychedelics group wrestles with new pharma identity

Former reverend arrested for allegedly killing 8

knowledge

New Alzheimer's drugs heat up race for early detection blood tests

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Maker of FluMist seeks to allow at

Democrats decry new health bill for going easy on private equity

Maker of FluMist seeks to allow at

Paying for Covid pills will soon shift to insurers

hotspot

focus

hotspot

entertainment